← Back to Clinical Trials
Recruiting NCT06944730

NCT06944730 Movement Quality and Balance Improvement in People With Chronic Low Back Pain Following Trunk Muscle Training

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06944730
Status Recruiting
Phase
Sponsor The Hong Kong Polytechnic University
Condition Chronic Low Back Pain (CLBP)
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2022-06-01
Primary Completion 2025-11-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 55 Years
Study Type INTERVENTIONAL
Interventions
Structural ExerciseIsolated Trunk ExerciseBack school

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2022-06-01 with a primary completion date of 2025-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this project is to assess if Chronic Low Back Pain (CLBP) participant's movement quality and balance variables can change after training that decreases their pain and disability. It will also compare the difference between structural exercise (SE) and isolated trunk exercise (ITE). The main questions it aims to answer are: 1. What are the effect of the training on the participant's movement quality and balance. 2. What are the difference between different types of trunk muscle training on people with CLBP. Researchers will compare SE, ITE and control. Control group will receive back school education that was shown not to be effective in reducing pain and disability. Participants will: 1. Do home and in-lab based SE or ITE training, or maintain active daily living over 2 months. 2. Complete the pain and disability questionnaire and do several physical functioning tests while having their trunk and lower limb movement and muscle activation measured.

Eligibility Criteria

Inclusion Criteria: * body mass index (BMI) 18-25 kg/m2 * experiencing intermittent pain lasting at least 3 months * had Oswestry Disability Index (ODI) score ranging between 17% and 45%. Exclusion Criteria: * exercise contraindication based on physical activity readiness questionnaire * indication or diagnosis of other chronic diseases (such as cancer, cardiovascular disease, diabetes, bone fracture, or infection) * artificial lower limb joints, history of spinal surgery, walking aid use * personal mobility restrictions (due to connective tissue diseases, rheumatoid arthritis, or central nervous system disorders) * pregnancy or within 1 year post partum

Contact & Investigator

Central Contact

Dhananjaya Sutanto, Ph.D.

✉ dhananjaya.sutanto@polyu.edu.hk

📞 +852 9680 7397

Principal Investigator

Billy CL So, Prof.

STUDY DIRECTOR

The Hong Kong Polytechnic University

Frequently Asked Questions

Who can join the NCT06944730 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Chronic Low Back Pain (CLBP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06944730 currently recruiting?

Yes, NCT06944730 is actively recruiting participants. Contact the research team at dhananjaya.sutanto@polyu.edu.hk for enrollment information.

Where is the NCT06944730 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT06944730 clinical trial?

NCT06944730 is sponsored by The Hong Kong Polytechnic University. The principal investigator is Billy CL So, Prof. at The Hong Kong Polytechnic University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology